ARTICLE | Clinical News
Aggrastat tirofiban regulatory update
July 18, 2016 7:00 AM UTC
FDA issued a complete response letter to Medicure for an sNDA for Aggrastat tirofiban to treat patients with ST-segment elevation myocardial infarction (STEMI). Medicure said the agency asked for addi...